Lite Strategy, Inc. Current Liabilities
Lite Strategy, Inc. (LITS) had Current Liabilities of $952.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-05-13
- 2026-03-31: Liabilities, Current $952.00K.
- 2025-12-31: Liabilities, Current $1.09M.
- 2025-09-30: Liabilities, Current $1.07M.
- 2025-06-30: Liabilities, Current $1.35M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $952.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.09M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $1.07M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.35M 10-Q · filed 2026-05-13 | |
| 2025-03-31 | $1.24M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.29M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $2.87M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $8.36M 10-K · filed 2025-09-26 | |
| 2024-03-31 | $9.62M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $8.04M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $8.56M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $20.34M 10-K · filed 2024-09-19 | |
| 2023-03-31 | $23.62M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $22.65M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $23.43M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $24.44M 10-K · filed 2023-09-26 | |
| 2022-03-31 | $23.96M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $22.67M 10-Q/A · filed 2022-05-23 | $30.52M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $20.84M 10-Q/A · filed 2022-05-23 | $30.36M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $20.21M 10-K · filed 2022-09-08 | $30.29M 10-K · filed 2021-09-02 |
| 2021-03-31 | $33.38M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $21.78M 10-Q/A · filed 2022-05-23 | $37.01M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $17.72M 10-Q/A · filed 2022-05-23 | $31.49M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $13.76M 10-K/A · filed 2022-05-23 | $23.30M 10-K · filed 2020-09-09 |
| 2020-03-31 | $10.26M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $9.93M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $10.07M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $14.30M 10-K · filed 2020-09-09 | |
| 2019-03-31 | $11.85M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.90M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $4.78M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $7.88M 10-K · filed 2019-08-28 | |
| 2018-03-31 | $4.48M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $5.21M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $4.46M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.87M 10-K · filed 2018-08-30 | |
| 2017-03-31 | $4.99M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $3.32M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $17.22M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.51M 10-K · filed 2017-09-05 | |
| 2016-03-31 | $4.03M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $3.38M 10-Q · filed 2016-02-05 | |
| 2015-09-30 | $3.13M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.96M 10-K · filed 2016-09-06 | |
| 2015-03-31 | $6.64M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $6.88M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $5.31M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.62M 10-K · filed 2015-09-02 | |
| 2014-03-31 | $3.52M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $2.43M 10-Q · filed 2014-02-11 | |
| 2013-09-30 | $1.47M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.68M 10-K · filed 2014-09-09 | |
| 2013-03-31 | $1.78M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.80M 10-Q · filed 2013-02-12 | |
| 2012-09-30 | $1.63M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.77M 10-K · filed 2013-09-18 | |
| 2012-03-31 | $1.50M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.30M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $1.59M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.37M 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |